Thermo Fisher to acquire Qiagen for €9B

Tuesday, 03. March 2020 12:00

United States manufacturer of scientific instruments Thermo Fisher Scientific Inc., announced on Tuesday it agreed to purchase the Dutch company Qiagen NV, a global provider of molecular diagnostics and sample preparation technologies, in a deal worth €9 billion.

It was agreed that investors receive €39 in cash for every Qiagen share. The offering price represents a 23% premium to Monday’s closing price of Qiagen’s stock in Frankfurt. "We are excited to bring together our complementary offerings to advance our customers' important work, from discovery to diagnostics," Thermo Fisher Scientific CEO Marc Casper said.

Qiagen shares jumped 17.05% to €37.75 at 11:59 am CET, while Thermo Fisher stock gained 1% selling for $308.00 premarket in New York on Tuesday.

Related Links: QIAGEN N.V.Thermo Fisher Scientific Inc.
Author:
Breaking the News / BJ